Modulation of Gene Expression in the Eye with Antisense Oligonucleotides.

antisense oligonucleotide cornea intraocular retina

Journal

Nucleic acid therapeutics
ISSN: 2159-3345
Titre abrégé: Nucleic Acid Ther
Pays: United States
ID NLM: 101562758

Informations de publication

Date de publication:
02 Nov 2023
Historique:
pmc-release: 01 12 2024
medline: 2 11 2023
pubmed: 2 11 2023
entrez: 2 11 2023
Statut: aheadofprint

Résumé

One advantage of antisense oligonucleotides (ASOs) for drug development is their long-lasting gene knockdown after administration

Identifiants

pubmed: 37917066
doi: 10.1089/nat.2023.0044
pmc: PMC10698777
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Annu Rev Vis Sci. 2019 Sep 15;5:151-175
pubmed: 31525145
Invest Ophthalmol Vis Sci. 2011 Mar 29;52(3):1865-71
pubmed: 21169533
Biomed Hub. 2017 Nov 17;2(3):1-10
pubmed: 31988919
Am J Ophthalmol. 2002 Apr;133(4):552-6
pubmed: 11931791
Nucleic Acid Ther. 2020 Aug;30(4):207-214
pubmed: 32202944
Cell Rep Methods. 2021 Dec 20;1(8):
pubmed: 35128514
Nat Neurosci. 2017 Apr;20(4):497-499
pubmed: 28192393
Invest Ophthalmol Vis Sci. 2015 Feb 26;56(3):2003-11
pubmed: 25722209
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4579-4585
pubmed: 28886202
Invest Ophthalmol Vis Sci. 2014 Jan 02;55(1):33-42
pubmed: 24255041
Ophthalmology. 2009 Sep;116(9):1818-30
pubmed: 19643492
N Engl J Med. 2015 Mar 26;372(13):1193-203
pubmed: 25692915
Invest Ophthalmol Vis Sci. 2019 Sep 3;60(12):3980-3991
pubmed: 31560764
JAMA Ophthalmol. 2016 Jul 1;134(7):810-6
pubmed: 27136069
Ophthalmology. 2016 Aug;123(8):1646-1652
pubmed: 27262764
Cornea. 2014 Jan;33(1):96-8
pubmed: 24270677
Ophthalmology. 2011 Apr;118(4):725-9
pubmed: 21035862
Am J Hum Genet. 2018 Apr 5;102(4):528-539
pubmed: 29526280
J Child Neurol. 2016 Jun;31(7):899-906
pubmed: 26823478
JAMA Ophthalmol. 2016 Feb;134(2):167-73
pubmed: 26633035
Exp Eye Res. 1983 Apr;36(4):493-503
pubmed: 6852130
Prog Retin Eye Res. 2021 Mar;81:100883
pubmed: 32735996
J Biol Chem. 2015 Mar 6;290(10):5979-90
pubmed: 25593321
Invest Ophthalmol Vis Sci. 2014 Oct 08;55(11):7073-8
pubmed: 25298419
N Engl J Med. 2017 Nov 2;377(18):1723-1732
pubmed: 29091570
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6308-6317
pubmed: 29242905
Ophthalmology. 2018 Feb;125(2):295-310
pubmed: 28923499
Hum Mol Genet. 2018 Mar 15;27(6):1015-1026
pubmed: 29325021
Nucleic Acids Res. 2018 Feb 28;46(4):1584-1600
pubmed: 29240946
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:81-105
pubmed: 27732800
PLoS One. 2012;7(11):e49083
pubmed: 23185296
Nucleic Acid Ther. 2019 Apr;29(2):73-81
pubmed: 30676271
JAMA Ophthalmol. 2015 Dec;133(12):1386-91
pubmed: 26401622

Auteurs

Jiaxin Hu (J)

Department of Pharmacology and Biochemistry, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

Xin Gong (X)

Department of Ophthalmology, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

Yan Fan (Y)

Department of Ophthalmology, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

Selina Aguilar (S)

Department of Pharmacology and Biochemistry, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
Department of Ophthalmology, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

Frank Rigo (F)

Ionis Pharmaceuticals, Carlsbad, California, USA.

Thahza P Prakash (TP)

Ionis Pharmaceuticals, Carlsbad, California, USA.

David R Corey (DR)

Department of Pharmacology and Biochemistry, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

V Vinod Mootha (VV)

Department of Ophthalmology, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
Eugene McDermott Center for Human Growth and Development, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

Classifications MeSH